Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-050973
Filing Date
2014-08-18
Accepted
2014-08-18 10:59:28
Documents
2
Period of Report
2014-08-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v386970_3.html 3  
1 OWNERSHIP DOCUMENT v386970_3.xml 3 11756
2 POWER OF ATTORNEY v386970_ex24.htm EX-24 4267
  Complete submission text file 0001144204-14-050973.txt   17538
Mailing Address 505 S. ROSA ROAD, SUITE 201 MADISON WI 53719
Business Address
NEIS JOHN (Reporting) CIK: 0001167426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 141048166

Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations